HIV/AIDS
Findings from the United Kingdom, United States and France describe new data in HIV/AIDS research
Published in AIDS Weekly, October 30th, 2006
Study 1: HIV RNA suppression is improved in HAART-naïve patients starting antiretroviral therapy with a three-drug/two-class regimen including efavirenz.
According to a recently published study from England, "Antiretroviral therapy has greatly reduced HIV mortality and morbidity. However, the best sequence of regimens and implications of initial regimen for long-term therapeutic success are not well defined."
"In INITIO, a large international randomized trial, we compared antiretroviral therapy with two nucleoside analogue reverse...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-10-30)
More Articles from AIDS Weekly
- HIV/AIDS Adverse Drug Reaction
Indinavir decreases nitric oxide production in HIV/AIDS patients - HIV/AIDS Drug Adherence
HIV serostatus disclosure associated with antiretroviral medication adherence - HIV/AIDS Osteonecrosis
Osteonecrosis is a complication of HIV infection and HAART - HIV/AIDS Pathogenesis
CTLA4 genotypes associated with clinical and virological outcomes following HIV-1 infection - HIV/AIDS Prognostics
CD4 count increase after initiating HAART moderately predicts undetectable viral load - HIV/AIDS Cancer
Research from Oregon Health & Science University, Vaccine and Gene Therapy Institute yields new data on HIV/AIDS cancer - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
